Free Trial
CVE:IGX

IntelGenx Technologies (IGX) Stock Price, News & Analysis

IntelGenx Technologies logo
C$0.58 +0.01 (+1.75%)
(As of 10/6/2021)

About IntelGenx Technologies Stock (CVE:IGX)

Key Stats

Today's Range
C$0.58
C$0.60
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.17
C$0.85
Volume
11,848 shs
Average Volume
56,279 shs
Market Capitalization
C$87.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

IGX Stock News Headlines

917 Trades… Zero Losses?
As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”
IntelGenx: Q1 Earnings Snapshot
Stocks in play: IntelGenx Corp.
IntelGenx Launches Preferred Share Regulation A Offering
See More Headlines

IGX Stock Analysis - Frequently Asked Questions

IntelGenx Technologies' stock was trading at C$0.58 at the beginning of 2024. Since then, IGX stock has increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2024 here
.

Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), F-star Therapeutics (FSTX), Trican Well Service (TCW), Aurora Cannabis (ACB), New Age Brands (NF), AutoZone (AZO) and Bonterra Energy (BNE).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Chemicals
CIK
N/A
Fax
N/A
Employees
2,050
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.75 million
Cash Flow
C$0.08 per share
Book Value
C$0.05 per share

Miscellaneous

Free Float
N/A
Market Cap
C$87.32 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (CVE:IGX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners